Polyether ionophores antibiotics group consists of natural, biologically active substances produced by Streptomyces spp species. Polyether antibiotics have antifungal, antibacterial, antiviral, antiparasitic, and tumor cell cytotoxicity properties. Commercially, polyether ionophores antibiotics are majorly used to control coccidiosis. It is also used as growth promoters in cattle. There are several drugs in polyether antibiotics category such as Salinomycin and monensin. Commercially available polyether antibiotics include lasalocid (Avatec, Bovatec), monensin (Coban, Rumensin, and Coxidin), narasin (Monteban, Maxiban), maduramycin (Cygro), salinomycin (Bio-cox, Sacox), laidlomycin (Cattlyst), and semduramycin (Aviax).

Polyether Antibiotics Market Drivers

High demand for livestock and increased consumption of milk, beef, and other food products is expected to drive the global polyether antibiotics market growth. Increasing demand for pork and poultry meat along with increase in pig farming and poultry is expected to propel demand for polyether antibiotics. This is owing to the susceptibility of poultry animals and other animals to various types of infections and diseases. High demand for poultry meat is expected to support global polyether antibiotics market growth over the forecast period. For instance, according to according to the U.S. Department of Agriculture, the people in the U.S. are expected to eat an estimated 93 pounds of chicken per person in 2018.

According to a research presented at July 2018 Chicken Marketing Summit (survey was commissioned by the National Chicken Council), majority of consumers (89 percent of respondents) wanted more information about the chicken they buy and eat. Moreover, 35% of the respondents were concerned about proper use of antibiotics in poultry animals. It was found that consumers were likely to buy more chicken if there concerns were answered. These factors are expected to support the global polyether antibiotics market growth over the forecast period. Moreover, in a 2016 survey by the U.S. poultry veterinarians about important diseases, coccidiosis ranked first in importance followed by Necrotic enteritis (NE). Increasing incidence of coccidiosis is further expected to support global polyether antibiotic market growth over the forecast period. According to a report by Federal Statistical Office in 2014, the U.S. was the largest producer of poultry meat with around 18% of the total meat produced worldwide. High production of poultry meat is expected to increase demand for polyether antibiotics in turn boosting the global polyether antibiotic market growth.

Some factors such as high administration of in-feed enzymes, stringent regulatory policies in the animal healthcare field, and increased use of substitute medicines including prebiotics are likely to restrain the global polyether antibiotic market growth over the forecast period.

Polyether Antibiotics Market Regional Analysis

North America polyether antibiotics market is expected to hold a dominant position in the global polyether antibiotics market over the forecast period, owing to high presence of key players in the region along with several strategic mergers and acquisitions amongst the key players. For instance, in 2015, U.S.-based Eli Lilly and Company acquired Novartis Animal Health Inc. and strengthen its position of Eli Lilly and Company’s animal health business arm Elanco US, Inc. in the region. Asia Pacific is expected to witness highest growth over the forecast period owing to high consumption rate of poultry meat. For instance, according to The United States Department of Agriculture (USDA) Foreign Agricultural Service, chicken meat consumption in China in 2017 was approximately 11.6 million metric tons

Polyether Antibiotics Market Key Players

Key players operating in the global polyether antibiotics market include Zoetis, Inc., Elanco Animal Health Inc., Hester Biosciences Limited, Huvepharma AD, Ceva Sante Animale, and Dechra Pharmaceuticals PLC.

Polyether Antibiotics Market Taxonomy:

The global polyether antibiotics market is segmented on the basis of drug, application, and region

By Drug: